Journal of Applied Physiology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 107: 1128-1137, 2009. First published August 6, 2009; doi:10.1152/japplphysiol.00609.2009
8750-7587/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/4/1128    most recent
00609.2009v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Google Scholar
Right arrow Articles by Casey, D. P.
Right arrow Articles by Wilkins, B. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, D. P.
Right arrow Articles by Wilkins, B. W.

Adenosine receptor antagonist and augmented vasodilation during hypoxic exercise

Darren P. Casey,1 Brandon D. Madery,1 Tasha L. Pike,1 John H. Eisenach,1 Niki M. Dietz,1 Michael J. Joyner,1 and Brad W. Wilkins2

1Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota; and ; 2Nike Sport Research Laboratory, Nike Incorporated, Beaverton, Oregon

Submitted 8 June 2009 ; accepted in final form 5 August 2009

We tested the hypothesis that adenosine contributes to augmented skeletal muscle vasodilation during hypoxic exercise. In separate protocols, subjects performed incremental rhythmic forearm exercise (10% and 20% of maximum) during normoxia and normocapnic hypoxia (80% arterial O2 saturation). In protocol 1 (n = 8), subjects received an intra-arterial administration of saline (control) and aminophylline (adenosine receptor antagonist). In protocol 2 (n = 10), subjects received intra-arterial phentolamine ({alpha}-adrenoceptor antagonist) and combined phentolamine and aminophylline administration. Forearm vascular conductance (FVC; in ml·min–1·100 mmHg–1) was calculated from forearm blood flow (in ml/min) and blood pressure (in mmHg). In protocol 1, the change in FVC ({Delta}FVC; change from normoxic baseline) during hypoxic exercise with saline was 172 ± 29 and 314 ± 34 ml·min–1·100 mmHg–1 (10% and 20%, respectively). Aminophylline administration did not affect {Delta}FVC during hypoxic exercise at 10% (190 ± 29 ml·min–1·100 mmHg–1, P = 0.4) or 20% (287 ± 48 ml·min–1·100 mmHg–1, P = 0.3). In protocol 2, {Delta}FVC due to hypoxic exercise with phentolamine infusion was 313 ± 30 and 453 ± 41 ml·min–1·100 mmHg–1 (10% and 20% respectively). {Delta}FVC was similar at 10% (352 ± 39 ml·min–1·100 mmHg–1, P = 0.8) and 20% (528 ± 45 ml·min–1·100 mmHg–1, P = 0.2) hypoxic exercise with combined phentolamine and aminophylline. In contrast, {Delta}FVC to exogenous adenosine was reduced by aminophylline administration in both protocols (P < 0.05 for both). These observations suggest that adenosine receptor activation is not obligatory for the augmented hyperemia during hypoxic exercise in humans.

aminophylline; systemic hypoxia; muscle blood flow



Address for reprint requests and other correspondence: D. P. Casey, Dept. of Anesthesiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: casey.darren{at}mayo.edu).




This article has been cited by other articles:


Home page
J. Physiol.Home page
D. P. Casey, B. D. Madery, T. B. Curry, J. H. Eisenach, B. W. Wilkins, and M. J. Joyner
Nitric oxide contributes to the augmented vasodilatation during hypoxic exercise
J. Physiol., January 15, 2010; 588(2): 373 - 385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.